AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 59787 — intervention group
Group type: EXPERIMENTAL
Intervention: Subunit vaccines containing hemagglutinin, neuraminidase, and nucleocapsids of A/Port Chalmers/1/73 (H3N2) influenza virus
Number of subjects: 0
Study 59787 — intervention group
Group type: EXPERIMENTAL
Intervention: Booster doses of antigen
Number of subjects: 0
Study 59787 — intervention group
Group type: COMPARATOR
Intervention: Intact influenza B virus vaccine
Number of subjects: 0
Study 59787 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher doses of the subunit vaccines (1,400 chick cell‐agglutinating units)
Number of subjects: 0
Study 31509069 — intervention group
Group type: EXPERIMENTAL
Intervention: Video group
Number of subjects: 17
Study 31509069 — intervention group
Group type: EXPERIMENTAL
Intervention: Teaching group
Number of subjects: 17
Study 31509069 — intervention group
Group type: EXPERIMENTAL
Intervention: Virtual group
Number of subjects: 17
Study 27417167 — intervention group
Group type: EXPERIMENTAL
Intervention: 18 months of supervised exercise training, actigraphy‐based counseling to reduce sedentary behavior, and individualized dietary counseling
Number of subjects: 140
Study 27417167 — intervention group
Group type: COMPARATOR
Intervention: Diet and activity counseling at baseline and at 9 months
Number of subjects: 140
Study 25948782 — intervention group
Group type: EXPERIMENTAL
Intervention: Iron-biofortified pearl millet (Fe-PM)
Number of subjects: 246
Study 25948782 — intervention group
Group type: COMPARATOR
Intervention: Control pearl millet (Control-PM)
Number of subjects: 246
Study 23863210 — intervention group
Group type: EXPERIMENTAL
Intervention: Probiotics (Bifidobacterium lactis BB‐12 1х10^9 CFU and Streptococcus thermophilus TH‐4 1х10^8 CFU)
Number of subjects: 60
Study 23863210 — intervention group
Group type: COMPARATOR
Intervention: Control group (no probiotics)
Number of subjects: 60
Study 23863210 — intervention group
Group type: EXPERIMENTAL
Intervention: Probiotics (Bifidobacterium lactis BB‐12 and Streptococcus thermophilus)
Number of subjects: 60
Study 21596248 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydrophobic IOL (Acrysof SA60AT)
Number of subjects: 63
Study 21596248 — intervention group
Group type: COMPARATOR
Intervention: Hydrophilic IOL (Meridian HP60M)
Number of subjects: 63
Study 21596248 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 63
Study 19358500 — intervention group
Group type: EXPERIMENTAL
Intervention: Catgut implantation at acupoints (Liangmen, Zhongwan, Tianshu, Qihai, Fenglong) for 2 courses (8 weeks total), once a week.
Number of subjects: 137
Study 19358500 — intervention group
Group type: EXPERIMENTAL
Intervention: Catgut implantation at acupoints for 2 courses (8 weeks total), once a week.
Number of subjects: 137
Study 16919056 — intervention group
Group type: EXPERIMENTAL
Intervention: Migraine subjects with active TrPs
Number of subjects: 20
Study 16919056 — intervention group
Group type: EXPERIMENTAL
Intervention: Migraine subjects
Number of subjects: 20
Study 16919056 — intervention group
Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 20
Study 15504990 — intervention group
Group type: EXPERIMENTAL
Intervention: 8 mg rosiglitazone
Number of subjects: 17
Study 15504990 — intervention group
Group type: COMPARATOR
Intervention: Insulin (premixed 70/30)
Number of subjects: 17
Study 11182215 — intervention group
Group type: EXPERIMENTAL
Intervention: Cilostazol (100-200 mg, two or four times daily for 12 months)
Number of subjects: 120
Study 11182215 — intervention group
Group type: COMPARATOR
Intervention: Placebo (control group)
Number of subjects: 120
Study 9763262 — intervention group
Group type: EXPERIMENTAL
Intervention: Radial nerve decompression
Number of subjects: 25
Study 9763262 — intervention group
Group type: COMPARATOR
Intervention: Radial motor nerve latency recordings in radial tunnel syndrome
Number of subjects: 25
Study 9763262 — intervention group
Group type: EXPERIMENTAL
Intervention: Radial nerve compression
Number of subjects: 25
Study 7522340 — intervention group
Group type: EXPERIMENTAL
Intervention: Atenolol
Number of subjects: 11
Study 7522340 — intervention group
Group type: EXPERIMENTAL
Intervention: Propranolol
Number of subjects: 11
Study 7522340 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 11
Study 2903602 — intervention group
Group type: EXPERIMENTAL
Intervention: Metoclopramide (Primperan)
Number of subjects: 40
Study 2903602 — intervention group
Group type: COMPARATOR
Intervention: Spasmofen (narcotic combination drug)
Number of subjects: 40
Study 31575448 — intervention group
Group type: EXPERIMENTAL
Intervention: Dilute betadine lavage (0.35%)
Number of subjects: 457
Study 31575448 — intervention group
Group type: COMPARATOR
Intervention: Normal saline lavage
Number of subjects: 457
Study 29866595 — intervention group
Group type: EXPERIMENTAL
Intervention: Not measuring prefeeding gastric residual volumes; measured only in the presence of bloody aspirates, vomiting, or abnormal abdominal examination.
Number of subjects: 87
Study 29866595 — intervention group
Group type: COMPARATOR
Intervention: Routine measurement of gastric residual volumes; feeding advancement based on gastric residual volume.
Number of subjects: 87
Study 28410960 — intervention group
Group type: EXPERIMENTAL
Intervention: Citywide ED care-coordination program
Number of subjects: 0
Study 28410960 — intervention group
Group type: COMPARATOR
Intervention: Treatment-as-usual
Number of subjects: 0
Study 25943490 — intervention group
Group type: EXPERIMENTAL
Intervention: Specific amino acid composition with micronutrients
Number of subjects: 32
Study 25943490 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 32
Study 25510093 — intervention group
Group type: EXPERIMENTAL
Intervention: Photoselective vaporization of the prostate (PVP)
Number of subjects: 120
Study 25510093 — intervention group
Group type: COMPARATOR
Intervention: Monopolar transurethral resection of the prostate (TURP)
Number of subjects: 120
Study 22115657 — intervention group
Group type: EXPERIMENTAL
Intervention: FFR-guided PCI of lesions with an FFR ≤0.80
Number of subjects: 328
Study 22115657 — intervention group
Group type: COMPARATOR
Intervention: Angiography-guided PCI of all lesions ≥50%
Number of subjects: 328
Study 19231774 — intervention group
Group type: EXPERIMENTAL
Intervention: Intraoperative cone-beam computed tomography using a mobile isocentric C-arm (PowerMobil; Siemens Medical Solutions) with different tube currents (4.6 mA, 3.3 mA, 2.3 mA, 1.2 mA, and 0.5 mA) and a current tube voltage of 100 kV
Number of subjects: 9
Study 16836631 — intervention group
Group type: EXPERIMENTAL
Intervention: EBQI (Evidence-Based Quality Improvement)
Number of subjects: 567
Study 16836631 — intervention group
Group type: COMPARATOR
Intervention: Usual Care
Number of subjects: 567
Study 12480288 — intervention group
Group type: EXPERIMENTAL
Intervention: Granules containing 40% MCCh with ibuprofen
Number of subjects: 0
Study 12480288 — intervention group
Group type: EXPERIMENTAL
Intervention: Granules containing 40% MCCh with furosemide
Number of subjects: 0
Study 10684748 — intervention group
Group type: EXPERIMENTAL
Intervention: Support staff intervention allowing ordering of fecal occult blood tests
Number of subjects: 1109
Study 10684748 — intervention group
Group type: COMPARATOR
Intervention: Standard care (control group)
Number of subjects: 1109
Study 10684748 — intervention group
Group type: EXPERIMENTAL
Intervention: Support staff intervention
Number of subjects: 1109
Study 9447414 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin A supplementation
Number of subjects: 0
Study 7943521 — intervention group
Group type: EXPERIMENTAL
Intervention: Ice wrap applied to one knee for 20 minutes before scanning
Number of subjects: 21
Study 7943521 — intervention group
Group type: COMPARATOR
Intervention: Room temperature wrap applied to the opposite knee
Number of subjects: 21
Study 3556257 — intervention group
Group type: EXPERIMENTAL
Intervention: 200 mg povidone-iodine pessaries, taken twice daily for five consecutive days
Number of subjects: 44
Study 3556257 — intervention group
Group type: COMPARATOR
Intervention: Placebo pessaries, taken twice daily for five consecutive days
Number of subjects: 44
Study 29292858 — intervention group
Group type: EXPERIMENTAL
Intervention: Abdominal obstetric binder (AOB) during colonoscopy (Group A)
Number of subjects: 451
Study 29292858 — intervention group
Group type: COMPARATOR
Intervention: No abdominal obstetric binder (Group B)
Number of subjects: 451
Study 27502883 — intervention group
Group type: EXPERIMENTAL
Intervention: Loupe magnification
Number of subjects: 22
Study 27502883 — intervention group
Group type: COMPARATOR
Intervention: Methylene blue dye
Number of subjects: 22
Study 25917315 — intervention group
Group type: EXPERIMENTAL
Intervention: voclosporin for 24 weeks
Number of subjects: 455
Study 25917315 — intervention group
Group type: EXPERIMENTAL
Intervention: cyclosporine for 24 weeks
Number of subjects: 455
Study 25917315 — intervention group
Group type: COMPARATOR
Intervention: placebo for 12 weeks followed by voclosporin for 12 weeks
Number of subjects: 455
Study 24282212 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypoxic training (13% FiO₂)
Number of subjects: 30
Study 24282212 — intervention group
Group type: COMPARATOR
Intervention: Normoxic training (21% FiO₂)
Number of subjects: 30
Study 21037954 — intervention group
Group type: EXPERIMENTAL
Intervention: High-intensive exercise program (5 weeks)
Number of subjects: 34
Study 21037954 — intervention group
Group type: COMPARATOR
Intervention: Control group (group discussion on hidden dysfunctions, no physical fitness training)
Number of subjects: 34
Study 21037954 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (IG and CG)
Number of subjects: 34
Study 18823487 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical Lactobacillus casei rhamnosus (Lcr35) vaginal capsules (10^9 CFU) for 7 days after antibiotic treatment
Number of subjects: 190
Study 18823487 — intervention group
Group type: COMPARATOR
Intervention: Standard antibiotic therapy for 7 days
Number of subjects: 190
Study 16359793 — intervention group
Group type: EXPERIMENTAL
Intervention: Gabapentin
Number of subjects: 0
Study 16359793 — intervention group
Group type: EXPERIMENTAL
Intervention: Morphine
Number of subjects: 0
Study 16359793 — intervention group
Group type: EXPERIMENTAL
Intervention: Gabapentin-morphine combination
Number of subjects: 0
Study 16359793 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 14555560 — intervention group
Group type: EXPERIMENTAL
Intervention: 100% oxygen
Number of subjects: 74
Study 14555560 — intervention group
Group type: COMPARATOR
Intervention: 28% oxygen
Number of subjects: 74
Study 11127762 — intervention group
Group type: EXPERIMENTAL
Intervention: estradiol 50 mg (E)
Number of subjects: 33
Study 11127762 — intervention group
Group type: EXPERIMENTAL
Intervention: estradiol 50 mg plus testosterone 50 mg implants (E&T)
Number of subjects: 33
Study 8708167 — intervention group
Group type: EXPERIMENTAL
Intervention: Pentoxifylline (PTX) 300 mg loading dose followed by continuous infusion of 1.2 mg/kg per h for 5 days
Number of subjects: 14
Study 8708167 — intervention group
Group type: COMPARATOR
Intervention: CVVH control group (no PTX)
Number of subjects: 14
Study 8708167 — intervention group
Group type: EXPERIMENTAL
Intervention: Pentoxifylline (PTX)
Number of subjects: 14
Study 1356398 — intervention group
Group type: EXPERIMENTAL
Intervention: Neostigmine 5, 15, 25, 35 or 45 micrograms kg‐1
Number of subjects: 72
Study 1356398 — intervention group
Group type: COMPARATOR
Intervention: Saline (control)
Number of subjects: 72
Study 3713748 — intervention group
Group type: EXPERIMENTAL
Intervention: Group practice
Number of subjects: 2299
Study 3713748 — intervention group
Group type: COMPARATOR
Intervention: Traditional clinic
Number of subjects: 2299
Study 29717699 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-management education (2-day group course)
Number of subjects: 404
Study 27358417 — intervention group
Group type: EXPERIMENTAL
Intervention: Fe‐Beans (86 mg Fe/kg), consumed 2 times/d for 128 days
Number of subjects: 195
Study 27358417 — intervention group
Group type: COMPARATOR
Intervention: Control‐Beans (50 mg Fe/kg), consumed 2 times/d for 128 days
Number of subjects: 195
Study 24933032 — intervention group
Group type: EXPERIMENTAL
Intervention: Insulin therapy
Number of subjects: 42
Study 23860793 — intervention group
Group type: EXPERIMENTAL
Intervention: Coated implant
Number of subjects: 120
Study 23860793 — intervention group
Group type: COMPARATOR
Intervention: Uncoated implant
Number of subjects: 120
Study 20516378 — intervention group
Group type: EXPERIMENTAL
Intervention: Clopidogrel 75 mg/d
Number of subjects: 15603
Study 20516378 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15603
Study 18784532 — intervention group
Group type: EXPERIMENTAL
Intervention: Nonresorbable membrane used to seal the lateral access window of the maxillary sinus after implant placement in 5 cases (group A)
Number of subjects: 10
Study 18784532 — intervention group
Group type: EXPERIMENTAL
Intervention: Replaceable bony window used to seal the lateral wall of the sinus in another 5 cases (group B)
Number of subjects: 10
Study 16015257 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-protein diet (14% protein, 53% carbohydrate, 30% fat)
Number of subjects: 20
Study 16015257 — intervention group
Group type: EXPERIMENTAL
Intervention: High-protein diet (25% protein, 35% carbohydrate, 30% fat)
Number of subjects: 20
Study 16015257 — intervention group
Group type: COMPARATOR
Intervention: Low-protein diet
Number of subjects: 20
Study 16015257 — intervention group
Group type: COMPARATOR
Intervention: High-protein diet
Number of subjects: 20
Study 12552040 — intervention group
Group type: EXPERIMENTAL
Intervention: milameline (muscarinic receptor agonist)
Number of subjects: 362
Study 10372249 — intervention group
Group type: EXPERIMENTAL
Intervention: Acarbose (n = 973, max dose 100 mg three times per day)
Number of subjects: 1946
Study 10372249 — intervention group
Group type: COMPARATOR
Intervention: Placebo (n = 973)
Number of subjects: 1946
Study 8665111 — intervention group
Group type: EXPERIMENTAL
Intervention: 5% glucose solution with 3 MBq of 99mtechnetium labelled DTPA
Number of subjects: 5
Study 8665111 — intervention group
Group type: EXPERIMENTAL
Intervention: iso‐osmotic maltodextrin solution with 3 MBq of 99mtechnetium labelled DTPA
Number of subjects: 5
Study 8665111 — intervention group
Group type: COMPARATOR
Intervention: Comparison of gastric emptying rates between glucose and maltodextrin solutions
Number of subjects: 5
Study 2002129 — intervention group
Group type: EXPERIMENTAL
Intervention: Behavioral Marital Therapy (BMT)
Number of subjects: 59
Study 2002129 — intervention group
Group type: COMPARATOR
Intervention: Insight-Oriented Marital Therapy (IOMT)
Number of subjects: 59
Study 6810839 — intervention group
Group type: EXPERIMENTAL
Intervention: Lithium carbonate
Number of subjects: 49
Study 6810839 — intervention group
Group type: EXPERIMENTAL
Intervention: Imipramine hydrochloride
Number of subjects: 49
Study 6810839 — intervention group
Group type: EXPERIMENTAL
Intervention: Lithium carbonate plus imipramine
Number of subjects: 49
Study 6810839 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 49
Study 29082807 — intervention group
Group type: EXPERIMENTAL
Intervention: Barbed suture (STRATAFIX™ Spiral PDO Knotless Tissue Control Device)
Number of subjects: 100
Study 29082807 — intervention group
Group type: COMPARATOR
Intervention: Conventional smooth suture (VICRYL™)
Number of subjects: 100
Study 29350383 — intervention group
Group type: COMPARATOR
Intervention: Two-finger technique with the newborn lying on the floor (Scenario A)
Number of subjects: 93
Study 29350383 — intervention group
Group type: COMPARATOR
Intervention: Two-finger technique with the newborn on a table (Scenario B)
Number of subjects: 93
Study 29350383 — intervention group
Group type: COMPARATOR
Intervention: Two-finger technique with the newborn on the rescuer's forearm (Scenario C)
Number of subjects: 93
Study 27517956 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous Glucose Monitoring (CGM) during Continuous Exercise (CON)
Number of subjects: 7
Study 27517956 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous Glucose Monitoring (CGM) during High-Intensity Interval Exercise (HIIE)
Number of subjects: 7
Study 27517956 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous Glucose Monitoring (CGM)
Number of subjects: 7
Study 24614694 — intervention group
Group type: EXPERIMENTAL
Intervention: Screening arm (PSA test performed)
Number of subjects: 4276
Study 24614694 — intervention group
Group type: COMPARATOR
Intervention: Control arm (no tests)
Number of subjects: 4276
Study 24614694 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall
Number of subjects: 4276
Study 22327894 — intervention group
Group type: EXPERIMENTAL
Intervention: Contour Profile Gel breast implants
Number of subjects: 955
Study 19641009 — intervention group
Group type: EXPERIMENTAL
Intervention: Point of care testing (PoCT) for haemoglobin A1c, urine albumin:creatinine ratio, lipids, and international normalized ratio (INR) using DCA 2000, Cholestech LDX, and CoaguChek S.
Number of subjects: 0
Study 19641009 — intervention group
Group type: EXPERIMENTAL
Intervention: Quality control (QC) program for PoCT devices.
Number of subjects: 0
Study 17998508 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediate spectacle correction of uncorrected refractive error
Number of subjects: 0
Study 17998508 — intervention group
Group type: COMPARATOR
Intervention: Delayed correction (after the 2‐month follow‐up visit)
Number of subjects: 0
Study 15894111 — intervention group
Group type: EXPERIMENTAL
Intervention: Eversion endarterectomy
Number of subjects: 70
Study 15894111 — intervention group
Group type: COMPARATOR
Intervention: Healthy volunteers (control)
Number of subjects: 70
Study 11955912 — intervention group
Group type: COMPARATOR
Intervention: Needle suturelysis (NS)
Number of subjects: 30
Study 11955912 — intervention group
Group type: EXPERIMENTAL
Intervention: Argon laser suturelysis (LS)
Number of subjects: 30
Study 9565933 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium bicarbonate (NaHCO3) 0.3 g.kg‐1
Number of subjects: 15
Study 9565933 — intervention group
Group type: COMPARATOR
Intervention: Placebo (white flour)
Number of subjects: 15
Study 9565933 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium bicarbonate (NaHCO3)
Number of subjects: 15
Study 7617799 — intervention group
Group type: EXPERIMENTAL
Intervention: Nicotine-abstinent condition
Number of subjects: 0
Study 7617799 — intervention group
Group type: COMPARATOR
Intervention: Non-abstinent condition (Control)
Number of subjects: 0
Study 7617799 — intervention group
Group type: EXPERIMENTAL
Intervention: Nicotine-abstinent smokers
Number of subjects: 0
Study 2233931 — intervention group
Group type: EXPERIMENTAL
Intervention: Warfarin
Number of subjects: 420
Study 385132 — intervention group
Group type: EXPERIMENTAL
Intervention: Baclofen
Number of subjects: 0
Study 385132 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 31911526 — intervention group
Group type: EXPERIMENTAL
Intervention: Tailored pharmacist intervention including reminders, habit-based strategies, family support, counselling, and strategies to address drug-related problems.
Number of subjects: 0
Study 31911526 — intervention group
Group type: COMPARATOR
Intervention: Usual care based on the Indonesian guideline.
Number of subjects: 0
Study 29381526 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified Otago Exercise Program (OEP) for 3 months
Number of subjects: 67
Study 29381526 — intervention group
Group type: COMPARATOR
Intervention: Conventional care
Number of subjects: 67
Study 28711113 — intervention group
Group type: EXPERIMENTAL
Intervention: Internet-based, ACT-influenced CBT intervention for eating disorders, lasting 8 weeks, with clinician support.
Number of subjects: 92
Study 28711113 — intervention group
Group type: COMPARATOR
Intervention: Waiting list control group (no intervention).
Number of subjects: 92
Study 28711113 — intervention group
Group type: EXPERIMENTAL
Intervention: Internet-based, ACT-influenced CBT intervention for eating disorders.
Number of subjects: 92
Study 25628348 — intervention group
Group type: COMPARATOR
Intervention: Endoscopic balloon dilation with steroid injection
Number of subjects: 130
Study 25628348 — intervention group
Group type: EXPERIMENTAL
Intervention: Radial incision and cutting with steroid injection
Number of subjects: 130
Study 23361846 — intervention group
Group type: EXPERIMENTAL
Intervention: Ticlopidine (CYP2B6 inhibitor), given orally for 4 days
Number of subjects: 0
Study 21809126 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture treatment (common needling on Zusanli (ST36), electroacupuncture on Sanyinjiao (SP6), Shuidao (ST28), and Scalp Reproduction Area, moxibustion on Shenque (CV8))
Number of subjects: 80
Study 21809126 — intervention group
Group type: COMPARATOR
Intervention: Acupoint injection with vitamin B12 at Sanyinjiao and Zusanli
Number of subjects: 80
Study 21809126 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture treatment
Number of subjects: 80
Study 21809126 — intervention group
Group type: COMPARATOR
Intervention: Acupoint injection with vitamin B12
Number of subjects: 80
Study 19835721 — intervention group
Group type: EXPERIMENTAL
Intervention: BMI >or=35 kg/m(2)
Number of subjects: 361
Study 19835721 — intervention group
Group type: EXPERIMENTAL
Intervention: BMI 30‐34.9 kg/m(2)
Number of subjects: 361
Study 19835721 — intervention group
Group type: EXPERIMENTAL
Intervention: Effective contraceptive use overall
Number of subjects: 361
Study 17903567 — intervention group
Group type: EXPERIMENTAL
Intervention: Experimental group conclusions favoring treatment efficacy
Number of subjects: 202
Study 17903567 — intervention group
Group type: EXPERIMENTAL
Intervention: Intent-to-treat analysis
Number of subjects: 202
Study 17903567 — intervention group
Group type: EXPERIMENTAL
Intervention: P values
Number of subjects: 202
Study 17903567 — intervention group
Group type: EXPERIMENTAL
Intervention: Confidence intervals
Number of subjects: 202
Study 17903567 — intervention group
Group type: EXPERIMENTAL
Intervention: Conclusions suggesting equivalence
Number of subjects: 202
Study 17903567 — intervention group
Group type: EXPERIMENTAL
Intervention: Publication bias for funded studies
Number of subjects: 202
Study 17903567 — intervention group
Group type: EXPERIMENTAL
Intervention: Power in studies suggesting equivalence
Number of subjects: 202
Study 15638817 — intervention group
Group type: EXPERIMENTAL
Intervention: L-arginine (3 g daily for 3 weeks)
Number of subjects: 61
Study 15638817 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 61
Study 11937178 — intervention group
Group type: EXPERIMENTAL
Intervention: Losartan
Number of subjects: 9193
Study 11937178 — intervention group
Group type: COMPARATOR
Intervention: Atenolol
Number of subjects: 9193
Study 9894821 — intervention group
Group type: EXPERIMENTAL
Intervention: Zinc supplementation (20 mg d(‐1) syrup with multivitamin (2 x RDA))
Number of subjects: 190
Study 9894821 — intervention group
Group type: EXPERIMENTAL
Intervention: Zinc supplementation
Number of subjects: 190